JAMA Ophthalmology : Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab for CRVO
Interview with Ian Leslie. Mcallister, FRANZCO, author of Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab Monotherapy for Central Retinal Vein Occlusion: A Randomized Clinical Trial (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 18, 2018 Category: General Medicine Source Type: podcasts
Anti-vascular endothelial growth factor (anti-VEGF) drugs for diabetic macular oedema
Diabetic macular oedema is a common complication of diabetes, in which damage to the blood vessels at the back of the eye leads to swelling. Lucentis, Eylea and Avastin are three antiangiogenic drugs that can be injected into the eye to treat the blood vessels and reduce the swelling. In June 2017, Gianni Virgili from the University of Florence in Italy, and colleagues, updated their Cochrane review of these drugs and used a network meta-analysis to compare their effects. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - July 12, 2017 Category: General Medicine Authors: Cochrane Source Type: podcasts
Anti-vascular endothelial growth factor (anti-VEGF) drugs for diabetic macular oedema
Diabetic macular oedema is a common complication of diabetes, in which damage to the blood vessels at the back of the eye leads to swelling. Lucentis, Eylea and Avastin are three antiangiogenic drugs that can be injected into the eye to treat the blood vessels and reduce the swelling. In June 2017, Gianni Virgili from the University of Florence in Italy, and colleagues, updated their Cochrane Review of these drugs and used a network meta-analysis to compare their effects.Note: The latest version of this review has been published on October 2018 but the conclusions as outlined in this podcast have not changed. (Source: Po...
Source: Podcasts from The Cochrane Library - July 12, 2017 Category: General Medicine Authors: Cochrane Source Type: podcasts
Anti-vascular endothelial growth factor (anti-VEGF) drugs for diabetic macular oedema
Diabetic macular oedema is a common complication of diabetes, in which damage to the blood vessels at the back of the eye leads to swelling. Lucentis, Eylea and Avastin are three antiangiogenic drugs that can be injected into the eye to treat the blood vessels and reduce the swelling. In June 2017, Gianni Virgili from the University of Florence in Italy, and colleagues, updated their Cochrane Review of these drugs and used a network meta-analysis to compare their effects. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - July 12, 2017 Category: General Medicine Authors: Cochrane Source Type: podcasts
Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy
Interview with Lee M. Jampol, MD, author of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - November 13, 2015 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
ASFH SNiPs and Ranibizumab
Guest: Sascha Fauser, MD
Professor Department of Ophthalmology University Hospital of Cologne Cologne, Germany (Source: As Seen From Here)
Source: As Seen From Here - May 18, 2014 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
ASFH SNiPs and Ranibizumab
Guest: Sascha Fauser, MD
Professor Department of Ophthalmology University Hospital of Cologne Cologne, Germany (Source: As Seen From Here)
Source: As Seen From Here - May 18, 2014 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
Topol Talks to Ferrara, $3M Breakthrough Prize Winner
Dr. Eric Topol talks with Dr. Napoleone Ferrara, recent winner of the Breakthrough Prize in Life Sciences and the researcher whose work led to the synthesis of bevacizumab and ranibizumab. (Source: Medscape Allergy and Immunology Podcast)
Source: Medscape Allergy and Immunology Podcast - May 2, 2013 Category: Allergy & Immunology Authors: Medscape Source Type: podcasts
Topol Talks to Ferrara, $3M Breakthrough Prize Winner
Dr. Eric Topol talks with Dr. Napoleone Ferrara, recent winner of the Breakthrough Prize in Life Sciences and the researcher whose work led to the synthesis of bevacizumab and ranibizumab. (Source: Medscape Critical Care Podcast)
Source: Medscape Critical Care Podcast - May 2, 2013 Category: Intensive Care Authors: Medscape Source Type: podcasts
ASFH Angioid Streaks and Ranibizumab
Guest: Eric Souied, MD, PhD
Head of Department of Ophthalmology
Hopital Intercommunal de Creteil
and Henri Mondor Hospital
Creteil, France (Source: As Seen From Here)
Source: As Seen From Here - December 2, 2010 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
ASFH Angioid Streaks and Ranibizumab
Guest: Eric Souied, MD, PhD
Head of Department of Ophthalmology
Hopital Intercommunal de Creteil
and Henri Mondor Hospital
Creteil, France (Source: As Seen From Here)
Source: As Seen From Here - December 2, 2010 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
ASFH Ranibizumab and Uveitic CME
Guest: Nisha Acharya, MD, MS
Assistant Professor, Director of the Uveitis Service
Proctor Foundation
University of California, San Francisco
San Francisco, CA (Source: As Seen From Here)
Source: As Seen From Here - August 18, 2009 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
ASFH Ranibizumab and Uveitic CME
Guest: Nisha Acharya, MD, MS
Assistant Professor, Director of the Uveitis Service
Proctor Foundation
University of California, San Francisco
San Francisco, CA (Source: As Seen From Here)
Source: As Seen From Here - August 18, 2009 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
ASFH Ranibizumab (Lucentis) Trials
Guest: Philip J. Rosenfeld, M.D., Ph.D.Professor of OphthalmologyBascom Palmer Eye InstituteUniversity of Miami Miller School of MedicineMiami, Florida (Source: As Seen From Here)
Source: As Seen From Here - November 19, 2006 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
